The neuroactive steroid 3α-hydroxy-5β-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptor

https://doi.org/10.1016/0922-4106(94)90082-5Get rights and content

Abstract

Neuroactive steroids allosterically inhibit [35S]t-butylbicyclophosphorothionate ([35S]TBPS) and enhance [3H]flunitrazepam binding to the GABAA receptor complex. In the presence of 5μM GABA, 3α-hydroxy-5β-pregnan-20-one (3α,5β-P) inhibits [35S]TBPS binding with high- (IC50 21–32 nM) and low- (IC50 24–63 μM) affinity components in bovine corical, cerebellar, and hippocampal membranes. The percentage of high-affinity sites ranges from 53% in cortex to 65% in cerebellum and hippocampus. However, 3α,5β-P is a single-site inhibitor in thalamus (IC50 43 nM). In the absence of GABA, similar affinities for the high- and low-affinity components were detected, although the percentages of high-affinity sites were reduced. Similarly, 3α,5β-P enhances [3H]flunitrazepam binding with high- (EC50 44–58 nM) and low- (EC50 2–13 μM) affinity components which account for 71–77% and 23–29% of the sites, respectively, in cortex, cerebellum and hippocampus. 3α,5β-P is a single-site enhancer in thalamus (EC50 80 nM). In contrast to 3α,5β-P, 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) is a single site modulator of [35S]TBPS and [3H]flunitrazepam binding in all regions examined. These data provide pharmacological evidence consistent with receptor heterogeneity for neuroactive steroids.

References (19)

There are more references available in the full text version of this article.

Cited by (61)

  • Mechanisms of neurosteroid interactions with GABA<inf>A</inf> receptors

    2007, Pharmacology and Therapeutics
    Citation Excerpt :

    The latter effect was proposed to result from channel block due to steroid binding to yet another site, distinct from those involved in potentiation or the type of inhibition produced by pregnenolone sulfate. Also, Morrow et al. (1990) found that the potentiation curves of muscimol-stimulated chloride uptake into rat brain synaptosomes were biphasic for many steroids suggesting that steroid interactions with multiple binding sites underlie their effects on the receptor, and others have found biphasic effects of 5β-reduced potentiating steroids on TBPS binding (Hawkinson et al., 1994). However, the caveat to these findings is that several subtypes of GABAA receptors, each with their own distinct pharmacological properties, could exist in the synaptoneurosome preparation used.

  • High affinity, heterogeneous displacement of [<sup>3</sup>H]EBOB binding to cerebellar GABA<inf>A</inf> receptors by neurosteroids and GABA agonists

    2005, Neuropharmacology
    Citation Excerpt :

    The minor high affinity component could be fitted only for the pooled experiments with IC50 values of about 4 nM (Table 2). Interestingly, displacement of cerebellar [3H]EBOB binding by allopregnanolone did not display this kind of heterogeneity (Fodor et al., 2005) such as that of [35S]TBPS binding (e.g. Hawkinson et al., 1994b). Displacement of [3H]EBOB binding was also studied by GABA agonists and neurosteroids in combination.

View all citing articles on Scopus
1

Present address: Department of Pharmaceutical Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Ave., Los Angeles, CA 90033, USA.

View full text